Aminophylline Export Market Intelligence: India's 151 Suppliers Shipping to 88 Countries — TransData Nexus 2026

Q: Who are the top aminophylline exporters from India?

The top aminophylline exporters from India are: 1. LINCOLN PHARMACEUTICALS LTD — $3.1M (53.6% market share); 2. ARCO PHARMA PRIVATE LIMITED — $248.0K (4.2% market share); 3. SRS PHARMACEUTICALS PRIVATE LIMITED — $184.0K (3.1% market share); 4. MANCARE PHARMACEUTICALS PRIVATE LIMITED — $175.7K (3.0% market share); 5. LINCOLN PHARMACEUTICALS LIMITED — $167.6K (2.9% market share). Together they account for 66.8% of India's total aminophylline export value.

Q: What is the total export value of aminophylline from India?

The total export value of aminophylline from India is $5.9M USD, recorded across 582 shipment transactions from 151 active exporters to 88 destination countries. The average shipment value is $10.1K.

Q: Which countries import aminophylline from India?

India exports aminophylline to 88 countries worldwide. The top importing countries are: TANZANIA (56.9% share, $3.3M), SERBIA (11.1% share, $650.9K), NIGERIA (5.4% share, $316.7K), MOZAMBIQUE (4.3% share, $252.0K), TURKMENISTAN (3.1% share, $184.0K). These five markets account for 80.8% of total export value.

Q: What is the average price of aminophylline exports from India?

The average unit price for aminophylline exports from India is $2.50 USD per unit, with prices ranging from $0.00 to $116.94 depending on formulation, packaging, and order volume. The total market is valued at $5.9M across 582 shipments.

Q: Which ports handle aminophylline exports from India?

The primary ports for aminophylline exports from India are SAHAR AIR (13.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.3% of shipments), JNPT/ NHAVA SHEVA SEA (8.1% of shipments), NHAVA SHEVA SEA (INNSA1) (7.9% of shipments), JNPT (6.2% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of aminophylline?

India is one of the world's leading exporters of aminophylline due to its large base of 151 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports aminophylline to 88 countries, demonstrating 45% global market coverage.

Q: What certifications do Indian aminophylline exporters need?

Indian aminophylline exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import aminophylline from India?

There are 249 registered buyers importing aminophylline from India, spread across 88 countries. The repeat buyer rate is 41.0%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top aminophylline supplier from India?

LINCOLN PHARMACEUTICALS LTD is the leading aminophylline exporter from India with a market share of 53.6% and total export value of $3.1M across 19 shipments. The top 5 suppliers together control 66.8% of total export value.

Suresh Sormare

Aminophylline

India Pharmaceutical Trade Intelligence

$5.9M151 Suppliers88 CountriesHS 30049099

ExportsIndia → TANZANIA56.9%India → SERBIA11.1%

Aminophylline Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Aminophylline to the World

Between 2022 and 2026, India exported $5.9M worth of aminophylline across 582 verified shipments to 88 countries — covering 45% of world markets in the Respiratory & OTC segment. The largest destination is TANZANIA (56.9%). LINCOLN PHARMACEUTICALS LTD leads with a 53.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Aminophylline export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Aminophylline export data snapshot — $5.9M · 151 exporters · 88 countriesTransData Nexus · Indian Customs Data

Top Aminophylline Exporters from India

151 active exporters · Ranked by export value

View all 151 →

Top Aminophylline Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	LINCOLN PHARMACEUTICALS LTD	$3.1M	19	4	53.6%
2	ARCO PHARMA PRIVATE LIMITED

Top Countries Importing Aminophylline from India

88 destination markets · Ranked by import value

All 88 countries →

Top Countries Importing Aminophylline from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	TANZANIA	$3.3M	56.9%
2	SERBIA	$650.9K	11.1%
3	NIGERIA	$316.7K	5.4%
4	MOZAMBIQUE	$252.0K	4.3%
5	TURKMENISTAN	$184.0K	3.1%
6	UGANDA	$121.7K	2.1%
7	CONGO DR	$89.5K	1.5%
8	SRI LANKA	$79.6K	1.4%
9	ANGOLA	$78.9K	1.3%
10	GREECE	$74.0K	1.3%

TANZANIA is India's largest aminophylline export destination, absorbing 56.9% of total exports worth $3.3M. The top 5 importing countries — TANZANIA, SERBIA, NIGERIA, MOZAMBIQUE, TURKMENISTAN — together account for 80.8% of India's total aminophylline export value. The remaining 83 destination countries collectively receive the other 19.2%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Aminophylline

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Aminophylline, a bronchodilator used in the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), has been approved in the United States through the Abbreviated New Drug Application (ANDA) pathway. According to the FDA's Orange Book, multiple ANDAs for aminophylline have been approved, indicating the presence of generic versions in the market. The most recent approval was granted in March 2025. As of March 2026, there are no active import alerts or significant regulatory actions concerning aminophylline, suggesting compliance with FDA standards.

Given the substantial number of Indian exporters—151 active entities—engaged in the export of aminophylline, it is imperative for these manufacturers to adhere strictly to FDA regulations. This includes compliance with Current Good Manufacturing Practices (cGMP) and ensuring that their products meet the requisite quality standards to maintain market access in the United States.

2EU & UK Regulatory Framework

In the European Union, aminophylline is subject to marketing authorization requirements overseen by the European Medicines Agency (EMA). The EMA mandates that manufacturers demonstrate the safety, efficacy, and quality of their products. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates the approval and monitoring of medicinal products, including aminophylline. Both agencies require adherence to Good Manufacturing Practice (GMP) standards, ensuring that products are consistently produced and controlled according to quality standards.

3WHO Essential Medicines & Global Standards

Aminophylline is included in the WHO Model List of Essential Medicines, underscoring its importance in treating priority health conditions. The 2025 edition of the WHO Model List includes over 520 medicines, reflecting the organization's commitment to ensuring access to essential treatments. Inclusion in this list signifies that aminophylline is considered vital for meeting the health needs of populations and should be available at all times in adequate amounts. Additionally, aminophylline is recognized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), which set the quality standards for medicinal substances.

4India Regulatory Classification

In India, aminophylline is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) oversees the pricing of essential medicines; however, as of March 2026, aminophylline is not listed under the Drug Price Control Order (DPCO), meaning it does not have a government-mandated ceiling price. For export purposes, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with export regulations.

5Patent & Exclusivity Status

Aminophylline is an established pharmaceutical compound with no active patents or exclusivity rights as of March 2026. This status allows for the production and marketing of generic versions, fostering competition and potentially leading to more affordable pricing in various markets.

6Recent Industry Developments

In June 2025, the NPPA announced a revision of ceiling prices for several essential medicines; however, aminophylline was not included in this revision, indicating its price remains market-driven. In August 2025, the CDSCO issued updated guidelines for the export of pharmaceutical products, emphasizing the need for stringent quality control measures, which directly impact aminophylline exporters. In October 2025, the WHO released the 2025 edition of the Model List of Essential Medicines, reaffirming aminophylline's status as an essential medicine. In December 2025, the EMA approved a new generic version of aminophylline, increasing competition within the European market. In February 2026, the FDA conducted inspections of several Indian pharmaceutical manufacturing facilities, including those producing aminophylline, to ensure compliance with cGMP standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Aminophylline

Retail & reference prices across 9 markets vs. India FOB export price of $2.50/unit

Global Price Benchmark for Aminophylline across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Specific pricing data for aminophylline is not readily available from U.S. government sources.
United Kingdom	N/A	GBP	The UK's NHS Drug Tariff does not list aminophylline tablets, indicating limited availability or usage.
Germany	N/A	EUR	Specific pricing data for aminophylline is not readily available from German regulatory sources.
Australia	N/A	AUD

Supply Chain Risk Assessment — Aminophylline

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Aminophylline, a bronchodilator used in the treatment of respiratory diseases, is synthesized from the active pharmaceutical ingredient (API) theophylline. The production of theophylline relies on specific key starting materials (KSMs), many of which are predominantly sourced from China. This dependency is part of a broader trend where China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a global leader in this sector.

The heavy reliance on Chinese KSMs introduces significant vulnerabilities into the supply chain. For instance, in 2024, environmental regulatory actions in China led to the shutdown of several chemical manufacturing facilities, causing disruptions in the supply of essential raw materials. These disruptions resulted in increased costs and supply shortages for Indian pharmaceutical manufacturers. Such events underscore the risks associated with over-dependence on a single country for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the export market for aminophylline from India is highly concentrated. The top five exporters account for 66.8% of total exports, with LINCOLN PHARMACEUTICALS LTD alone contributing 53.6% ($3.1 million USD). This high level of supplier concentration poses a significant single-source risk. Any operational or regulatory issues affecting these key exporters could disrupt the supply chain and impact global availability.

Access Complete Aminophylline Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 582 transactions across 88 markets.

Request Demo View Pricing

Frequently Asked Questions — Aminophylline Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top aminophylline exporters from India?

The leading aminophylline exporters from India are LINCOLN PHARMACEUTICALS LTD, ARCO PHARMA PRIVATE LIMITED, SRS PHARMACEUTICALS PRIVATE LIMITED, and 10 others. LINCOLN PHARMACEUTICALS LTD leads with 53.6% market share ($3.1M). The top 5 suppliers together control 66.8% of total export value.

What is the total export value of aminophylline from India?

The total export value of aminophylline from India is $5.9M, recorded across 582 shipments from 151 active exporters to 88 countries. The average shipment value is $10.1K.

Which countries import aminophylline from India?

India exports aminophylline to 88 countries. The top importing countries are TANZANIA (56.9%), SERBIA (11.1%), NIGERIA (5.4%), MOZAMBIQUE (4.3%), TURKMENISTAN (3.1%), which together account for 80.8% of total export value.

What is the HS code for aminophylline exports from India?

The primary HS code for aminophylline exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Aminophylline

Aminophylline

How India Exports Aminophylline to the World

Top Aminophylline Exporters from India

Top Countries Importing Aminophylline from India

Quick Facts

Related Respiratory & OTC

Related Analysis

Need Details?

Regulatory Landscape — Aminophylline

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Aminophylline

Supply Chain Risk Assessment — Aminophylline

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Aminophylline Trade Intelligence

Frequently Asked Questions — Aminophylline Exports from India

Who are the top aminophylline exporters from India?

What is the total export value of aminophylline from India?

Which countries import aminophylline from India?

What is the HS code for aminophylline exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of aminophylline exports from India?

Which ports handle aminophylline exports from India?

Why is India a leading exporter of aminophylline?

What certifications do Indian aminophylline exporters need?

How many buyers import aminophylline from India?

What is the market share of the top aminophylline exporter from India?

Analysis Methodology